This is not the most recent version of the article. View current version (21 JAN 2009)

Intervention Protocol

Alkylating agents for Waldenstrom's macroglobulinemia

  1. K Yang,
  2. JL Tan,
  3. TX Wu

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 17 OCT 2007

DOI: 10.1002/14651858.CD006719.pub2


How to Cite

Yang K, Tan JL, Wu TX. Alkylating agents for Waldenstrom's macroglobulinemia (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006719. DOI: 10.1002/14651858.CD006719.pub2.

Author Information

*A/Prof Taixiang Wu, Associate Professor, Chinese Cochrane Centre, Chinese EBM Centre, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, CHINA. txwutx@hotmail.com.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 17 OCT 2007

SEARCH

This is not the most recent version of the article. View current version (21 JAN 2009)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the effectiveness and safety of the alkylating agents for Waldenstrom Macroglobulinemia